Maryland Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-112	Closed	-$7K	–	231
2022 Q3	$7K	Buy	+112	New	+$7K	0.01%	181